The article you requested is
Epidemiology, Clinical Consequences, and Psychosocial Treatment of Nonadherence in Schizophrenia.
J Clin Psychiatry 2006;67(suppl 5):3-8
© Copyright 2017 Physicians Postgraduate Press, Inc.
Access to this article is available to valid users
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Register: If you do not have one already, register for a free account.
Partial adherence and nonadherence to medication continue to be problems in the treatment of patients
with schizophrenia. Nonadherence to medication has a negative impact on the course of illness
for these patients as is shown by data on relapse, rehospitalization, time to remission, and attempted
suicide. Several factors that contribute to poor adherence have been identified and need to be taken
into account when attempting to address the problem of nonadherence. These risk factors relate to the
patient, his or her illness and social situation, and the physician. Among the measures that have the
potential to improve adherence to medication are psychosocial interventions, psychoeducation in the
form of professional, peer-to-peer or family-to-family interventions, and shared decision making.